Sign in to follow
Search Results

0 results for 'Eli Lilly'

You can use to get even better search results
May 01, 2013 |

Stepping Up to the Plate

The general counsel of the baseball players union always goes to bat for his men; and other Moves.
11 minute read
September 12, 2003 |

Federal Circuit Strengthens Patent Protection for Research Tools

In Integra Lifesciences I, Ltd. v. Merck KgaA, the U.S. Court of Appeals for the Federal Circuit dramatically narrowed the safe harbor from patent infringement afforded to drug developers under 35 U.S.C. � 271(e)(1) -- the "safe harbor" provision of the Hatch-Waxman Act -- and restored the vitality of patent rights with respect to research tools.
10 minute read
August 24, 2010 |

Daily Decision Service Alert: Vol. 19, No. 162 - August 24 2010

Daily decision alert.
12 minute read
October 15, 2003 |

Law Firms Become Defendants in Patent Fight

2 minute read
December 07, 2004 |

Awash in Vioxx Suits, Merck Is Recruiting Big-Time Help

Arming for a looming courtroom battle over its Vioxx arthritis drug, Merck & Co. has hired a handful of firms for its defense. The lead firm could receive as much as $50 million for its work on Vioxx litigation, according to observers. In addition to the financial considerations, the task of compiling an outside legal team may present special challenges for a company that highly values privacy and prefers to turn to its in-house lawyers.
9 minute read
May 01, 2001 |

How Cooper Carvin Came Apart

Washington, D.C.-based Cooper, Carvin & Rosenthal was founded only five years ago by two former DOJ officials in the Reagan administration. The firm enjoyed a lucrative and politically charged practice -- until recently. Three top associates were hired away by President George W. Bush and a handful of partners jumped ship. But Charles Cooper, the de facto managing partner of the firm, still says, "I love my practice."
7 minute read
April 24, 2007 |

Problems With the Patent System: Nothing Cash Can't Cure

A new patent reform bill was introduced in Congress on April 18, and the lobbyists are circling. Some points receive nearly unanimous support -- the Patent and Trademark Office is overburdened, and it's time for America to dump its unique first-to-invent system for the first-to-file system common in the rest of the world -- but others are the subject of hot debate. High-tech companies are spending more than ever to convince legislators that change is good, but what's really needed depends on who you ask.
9 minute read
March 29, 2010 |

Direct to Consumer Pharma Marketing, Tonight on 'The American Law Journal'

American doctors wrote more than 164 million prescriptions for antidepressants in 2008. How much was that due to direct to consumer drug advertising? Aside from the moral questions, how does that advertising affect pharmaceutical product litigation and what happens in the courtroom?
2 minute read
March 01, 2006 |

Saving Vaccines

12 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • A Buyer's Guide to Law Firm Software

      Brought to you by PracticePanther

      Download Now

    • A Step-by-Step Flight Plan for Legal Teams: Fire Up Your Productivity Engine and Deliver High-Impact Work Faster

      Brought to you by HaystackID

      Download Now

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now